Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) EBT Margin (2020 - 2025)

Historic EBT Margin for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to 13.13%.

  • Journey Medical's EBT Margin rose 32100.0% to 13.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.38%, marking a year-over-year increase of 171400.0%. This contributed to the annual value of 26.03% for FY2024, which is 214400.0% down from last year.
  • Journey Medical's EBT Margin amounted to 13.13% in Q3 2025, which was up 32100.0% from 24.89% recorded in Q2 2025.
  • In the past 5 years, Journey Medical's EBT Margin registered a high of 48.88% during Q3 2023, and its lowest value of 99.99% during Q2 2021.
  • Over the past 5 years, Journey Medical's median EBT Margin value was 31.0% (recorded in 2025), while the average stood at 36.49%.
  • As far as peak fluctuations go, Journey Medical's EBT Margin plummeted by -1015100bps in 2021, and later surged by 1113700bps in 2023.
  • Journey Medical's EBT Margin (Quarter) stood at 76.59% in 2021, then rose by 13bps to 66.57% in 2022, then soared by 80bps to 13.22% in 2023, then soared by 188bps to 11.62% in 2024, then plummeted by -213bps to 13.13% in 2025.
  • Its last three reported values are 13.13% in Q3 2025, 24.89% for Q2 2025, and 31.0% during Q1 2025.